Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression
Advanced Science · 2024
DOI: 10.1002/advs.202306229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Xihan Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Experimental Teratology, Ministry of Education, Department of Obstetrics and Gynecology, Qilu Hospital, Department of Cell Biology,…. Hauptthemen laut MEDLINE: Intellectual Disability, Ovarian Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Translational Medicine Core Facility of Shandong University, Laboratory Animal Center of Shandong University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Splicing factor polyglutamine binding protein‐1 (PQBP1) is abundantly expressed in the central nervous system during development, and mutations in the gene cause intellectual disability. However, the roles of PQBP1 in cancer progression remain largely unknown. Here, it is shown that PQBP1 overexpression promotes tumor progression and indicates worse prognosis in ovarian cancer. Integrative analysis of spyCLIP‐seq and RNA‐seq data reveals that PQBP1 preferentially binds to exon regions and modulates exon skipping. Mechanistically, it is shown that PQBP1 regulates the splicing of genes related to the apoptotic signaling pathway, including BAX. PQBP1 promotes BAX exon 2 skipping to generate a truncated isoform that undergoes degradation by nonsense‐mediated mRNA decay, thus making cancer cells resistant to apoptosis. In contrast, PQBP1 depletion or splice‐switching antisense oligonucleotides promote exon 2 inclusion and thus increase BAX expression, leading to inhibition of tumor growth. Together, the results demonstrate an oncogenic role of PQBP1 in ovarian cancer and suggest that targeting the aberrant splicing mediated by PQBP1 has therapeutic potential in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Experimental Teratology, Ministry of Education, Department of Obstetrics and Gynecology, Qilu Hospital, Department of Cell Biology, School of Basic Medical Science, Shandong University, Jinan, 250012,…
- Advanced Medical Research Institute, Shandong University, Jinan, 250012, China.
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.
- Department of Pathology, Northwestern University School of Medicine, Chicago, IL, 60611, USA.
- Department of Ophthalmology, Qilu Hospital, Shandong University, Jinan, 250012, China.
- Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine, Soochow University, Suzhou, 215127, China.
ORCID-Profile: Zhaojian Liu
Förderung
- Translational Medicine Core Facility of Shandong University
- Laboratory Animal Center of Shandong University
- National Natural Science Foundation of China
- National Key Technology Research and Development Programme of China
Zitieren
APA
Liu, X., Zhang, J., Wang, Z., Yan, M., Xu, M., Li, G., Shender, V., Wei, J. J., Li, J., Shao, C., Zhang, S., Kong, B., Song, K., & Liu, Z. (2024). Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression. Advanced Science. https://doi.org/10.1002/advs.202306229
Vancouver
Liu X, Zhang J, Wang Z, Yan M, Xu M, Li G, et al. Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression. Advanced Science. 2024. doi:10.1002/advs.202306229
BibTeX
@article{Liu2024,
author = {Liu, Xihan and Zhang, Jiaojiao and Wang, Zixiang and Yan, Mingyao and Xu, Meining and Li, Gaoyuan and Shender, Victoria and Wei, Jian-Jun and Li, Jianqiao and Shao, Changshun and Zhang, Shiqian and Kong, Beihua and Song, Kun and Liu, Zhaojian},
title = {Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202306229}
}
EUVIMED